| Neochem Bio Solutions Ltd | Industry : Chemicals | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | ||
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 6.68 | 6.68 | 5.43 | 3.00 | |
| Reserves | 13.08 | 5.64 | 2.96 | 1.09 | |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Shareholders Funds | 19.76 | 12.32 | 8.39 | 4.09 | |
| Secured Loans | 30.88 | 26.01 | 19.53 | 16.50 | |
| Unsecured Loans | 4.75 | 7.32 | 6.64 | 6.77 | |
| Total Debt | 35.63 | 33.33 | 26.17 | 23.27 | |
| Other Liabilities | 0.31 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 55.70 | 45.65 | 34.56 | 27.36 | |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 24.30 | 23.60 | 18.46 | 15.01 | |
| Less: Accumulated Depreciation | 5.63 | 4.80 | 3.79 | 2.57 | |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Block | 18.67 | 18.80 | 14.67 | 12.44 | |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work in Progress | 0.06 | 0.03 | 0.04 | 0.15 | |
| Investments | 0.00 | 0.00 | 0.09 | 0.09 | |
| Current Assets, Loans & Advances | |||||
| Inventories | 23.76 | 18.21 | 14.93 | 13.29 | |
| Sundry Debtors | 24.89 | 16.80 | 14.16 | 13.63 | |
| Cash and Bank Balance | 0.05 | 0.35 | 0.05 | 0.39 | |
| Loans and Advances | 3.47 | 2.29 | 2.58 | 1.81 | |
| Total Current Assets | 52.18 | 37.65 | 31.72 | 29.12 | |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 19.30 | 16.18 | 14.88 | 18.02 | |
| Provisions | 2.78 | 0.90 | 0.50 | 0.28 | |
| Total CL & Provisions | 22.09 | 17.08 | 15.38 | 18.30 | |
| Net Current Assets | 30.09 | 20.57 | 16.34 | 10.82 | |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liability | 0.60 | 0.74 | 0.74 | 0.72 | |
| Net Deferred Tax | -0.60 | -0.74 | -0.74 | -0.72 | |
| Other Assets | 7.47 | 6.96 | 4.15 | 4.57 | |
| Total Assets | 55.69 | 45.63 | 34.55 | 27.36 | |
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |